REGENXBIO, Inc. (RGNX)
8.48
+0.38
(+4.69%)
USD |
NASDAQ |
Mar 23, 12:33
REGENXBIO Accounts Payable (Quarterly) : 21.36M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 280.84M |
| AbbVie, Inc. | 34.42B |
| Krystal Biotech, Inc. | 3.238M |
| Replimune Group, Inc. | 5.647M |
| Ocugen, Inc. | 6.202M |